下腔静脉畸形的64层螺旋CT表现

目的 探讨64层螺旋CT下腔静脉畸形的影像表现.方法 回顾性分析6986例受检者的腹部64层螺旋CT增强扫描资料,共发现25例下腔静脉先天畸形.分析下腔静脉畸形的影像表现.结果 25例下腔静脉畸形中包括左下腔静脉6例,CT表现为肾下段腹主动脉左侧上行的下腔静脉.双下腔静脉10例,CT表现为肾下段腹主动脉两侧上行的下腔静脉.左肾静脉畸形5例,CT增强扫描横断面显示腹主动脉后和环主动脉走行的左肾静脉.肝下段下腔静脉中断伴奇静脉延续2例,胸腹部CT增强扫描显示肝段至肾上段下腔静脉缺如,肾段下腔静脉由奇静脉延续回流人上腔静脉,而肝静脉直接回流右心房.腔静脉血管造影见对比剂经增粗的奇静脉和半奇静脉通过上腔静脉回流右心房.肝下段下腔静脉中断伴门静脉延续1例,增强CT显示下腔静脉直接与门静脉在肝门部连接,肝门部门静脉呈瘤样扩张.左下腔静脉伴半奇静脉延续1例,增强CT可见左下腔静脉与半奇静脉连接,上行汇入奇静脉.结论 64层螺旋CT可清晰显示下腔静脉及其属支的畸形,可成为下腔静脉畸形的重要诊断方法.     

中国河南地区Budd-Chiari综合征病变特点的影像分析

目的 探讨中国河南省Budd-Chiari综合征患者肝静脉阻塞和下腔静脉阻塞病变的分布特点.方法 应用3种血管成像技术,彩色多普勒超声、CTA和MRA检查,经DSA证实的Budd-Chiari综合征患者231例,对影像结果进行分析,分析清晰显影的主肝静脉、副肝静脉和下腔静脉走行与阻塞部位分布特点.结果 231例中肝静脉分支都正常的单纯性下腔静脉阻塞5例,占2.2%;下腔静脉正常的单纯性肝静脉阻塞33例,占14.3%;下腔静脉和肝静脉同时阻塞的193例,占83.5%.结论 中国河南地区Budd-Chiari综合征以下腔静脉阻塞合并肝静脉阻塞的复合型病变最多见,而单纯性下腔静脉阻塞最少见.     

Budd-Chiari综合征的CT与超声、静脉造影对比研究

目的：评价ＣＴ、超声、静脉造影对Ｂｕｄｄ－Ｃｈｉａｒｉ综合征的诊断价值。方法：回顾性分析４４例Ｂｕｄｄ－Ｃｈｉａｒｉ综合征的ＣＴ、超声、静脉造影表现,比较三种检查方法显示肝脏的形态、肝静脉、下腔静脉、肝内外的侧枝血管情况。结果：ＣＴ显示肝尾叶增大４２例（９５％）,肝脏密度不均或呈低密度表现,１９例（４３％）显示有肝内侧枝血管,４２例（９５％）见有肝外侧枝血管,其中奇静脉扩张３５例（８０％）,半奇静脉扩张３９例（８９％）,下腔静脉钙化７例（１６％）。超声显示３８例（８６％）有下腔静脉狭窄或阻塞,１６例（３６％）有肝静脉狭窄或阻塞,３７例（８４％）显示有肝内侧枝血管,１６例（３６％）显示有肝外侧枝血管。静脉造影显示下腔静脉狭窄或阻塞２３例（５３％）,肝静脉狭窄或阻塞５例（１１％）,其余１６例（３６％）同时累及下腔静脉和肝静脉,３８例（８４％）显示有肝内侧枝血管,４４例（１００％）见有肝外侧枝血管。结论：ＣＴ对显示肝脏形态、下腔静脉钙化、肝外侧枝血管尤其是奇静脉和半奇静脉扩张有优势,超声则对显示下腔静脉和肝静脉狭窄或阻塞、肝内侧枝血管有优势,ＣＴ、超声和静脉造影相互补充有助于本病的正确诊断     

Budd-Chiari syndrome: CT observations

The authors describe four patients with Budd-Chiari syndrome in whom contrast material-enhanced computed tomographic (CT) scans demonstrated low-density venous thrombosis in three sites not, to our knowledge, previously described with this modality. Thrombosis was seen in the portal circulation, the hepatic veins, and the intrahepatic inferior vena cava. It is known that concomitant portal vein thrombosis may be seen in 20% of patients with Budd-Chiari syndrome. Three of the four patients in the current study had this finding, one with extensive thrombosis of portal, mesenteric, and splenic veins and the other two with portal vein branch involvement. In one patient hepatic vein thrombosis was demonstrated with CT, and in three inferior vena cava clot was demonstrated. All four patients had the distinctive hepatic parenchymal contrast enhancement pattern seen in this condition, which the authors think may be at least partially caused by associated portal thrombosis. The presence of portal venous thrombosis should prompt the observer to consider the diagnosis of Budd-Chiari syndrome. Detection of hepatic vein clot confirms the diagnosis and may be seen in this condition in association with inferior vena cava thrombus.     

3D CE-MRA在评价腹部静脉系统中的应用

目的探讨三维增强磁共振血管成像（3DCE—MRA）技术在腹部静脉系统中的应用价值。方法收集具有完整资料的16例病例，先行常规MRI检查，随后经静脉注射Gd—DTPA20—30mL后连续三次行3DCE—MRA采集数据，对静脉系统原始图像进行MIP重建。主要观察指标为下腔静脉、脾静脉、肝静脉、肠系膜上静脉、门静脉形态变化。结果16例患者中，门腔静脉正常者9例，3DCE—MRA清晰显示下腔静脉、肝静脉、脾静脉、肠系膜上静脉、门静脉结构；门静脉高压3例，示脾静脉增宽迂曲，门静脉主干增宽及明显侧支循环形成；2例布加氏综合征；1例下腔静脉血栓形成；1例门静脉海绵样改变。结论3DCE—MRA是一种安全、敏感性高的血管造影技术，可提高腹部静脉系统疾病的术前诊断。     

肝内门静脉和肝静脉的解剖与变异(三维动态增强磁共振血管成像分析)

目的用三维动态增强磁共振血管成像（３ｄｉｍｅｎｔｉｏｎａｌｄｙｎａｍｉｃｃｏｎｔｒａｓｔｅｎｈａｎｃｅｄＭＲＡ,３ＤＤＣＥＭＲＡ）前瞻性地观测肝内门静脉（简称门脉）和肝静脉的解剖和变异。方法共进行１４２例门脉和肝静脉３ＤＤＣＥＭＲＡ检查。对肝内门脉和肝静脉的解剖和变异做分型,计算每一型所占总调查人数的比例,并计算右后下肝静脉的显示率。结果１４２次成像中,８例（５．６％）显示门脉呈三分叉状,７例（４．９％）门脉先分出右后支,然后上行分为左支和右前支,４例（２．８％）门脉右前支源于左支,未发现有门脉左支水平段或右支缺如,余下１２３例（８６．６％）显示正常门脉分支。绝大多数情况下（９５．１％）肝中、肝左静脉合并,而三大支肝静脉单独汇入下腔静脉仅占４．９％。右后下肝静脉的显示率为７．７％。结论肝内门脉变异并不少见。肝中和肝左静脉多合并后汇入下腔静脉。部分病人有较为粗大的右后下肝静脉。３ＤＤＣＥＭＲＡ能方便而清楚地显示上述血管的解剖和变异     

CT features of abdominal manifestations of primary antiphospholipid syndrome.

PURPOSE: The purpose of this work was to evaluate the CT features of the abdominal manifestations of primary antiphospholipid syndrome (PAPS). METHOD: Of the 32 patients who were confirmed to have PAPS among 751 patients with elevated antiphospholipid antibodies during a 2 year period, we retrospectively reviewed the 14 patients who underwent abdominal CT. The clinical indications for abdominal CT included abdominal pain, abdominal distension, or lower leg swelling. CT findings were analyzed with regard to the abdominal vascular system and abdominal organ involvement patterns as well as ancillary findings. RESULTS: Of the 14 patients with PAPS, 10 had involvement of the venous system (72%), 2 of the arterial system (14%), and 2 of both systems (14%). Of the 12 patients who had venous system involvement, 4 had thrombosis in the inferior vena cava (IVC), 2 in both the IVC and the hepatic vein, 1 in the IVC and splenic and portal veins, 1 in the IVC and hepatic and adrenal veins, 1 in the hepatic, portal, and renal veins, and 3 in the portal and superior mesenteric veins. Budd-Chiari syndrome developed in five of the nine patients who had thrombosis of the IVC or hepatic vein. Arterial thrombosis was noted in four patients, hepatic artery in two, aorta in one, renal artery in one, pancreatic arcade in one, and splenic artery in one, with infarct of multiple organs including the liver, jejunum, colon, kidney, and adrenal gland. Seven of the 14 patients (50%) manifested thrombosis or infarct of multiple extra-abdominal organs. CONCLUSION: PAPS should be included in the differential diagnosis when CT demonstrates infarcts in multiple organs or patients have recurrent episodes of venous or arterial thrombosis.     

Hepatic vascular anatomy on magnetic resonance imaging

This study evaluated the ability of magnetic resonance imaging (MRI) to depict the hepatic vasculature and surgical anatomy of the liver using the transaxial, coronal, and sagittal planes. Retrospective analysis of the abdominal MRI examinations of 94 patients was performed. The spin-echo imaging technique was used to obtain transaxial images in all patients and coronal and sagittal sections in 35 of these patients. Overall, the hepatic vasculature was better delineated on the longer repetition rates (2000 msec TR) and the first echo images (28 msec TE). The inferior vena cava, right and middle hepatic veins, and main and right portal veins were seen in 100% of the cases in the transaxial plane. The left hepatic vein was seen in 98%, the left portal vein in 93%, and the hepatic artery in 44% in the transaxial plane. In the sagittal and coronal planes, the inferior vena cava and main and right portal veins were seen in 100% of cases. The other hepatic vasculature was less frequently demonstrated. In the sagittal plane, the right hepatic vein was seen in 85% of the cases, the left hepatic vein in 62%, the middle hepatic vein in 90%, the left portal vein in 90%, and the hepatic artery in 14%. In the coronal plane, the right hepatic vein was seen in 85% of cases, the left hepatic vein in 14%, the middle hepatic vein in 79%, the left portal vein in 71%, and the hepatic artery in 7%. These results are from preliminary work. Further developments with MRI technology may render better visualization of hepatic vasculature.     

Clinical relevance of retrograde inferior vena cava or hepatic vein opacification during contrast-enhanced CT

OBJECTIVE: The purpose of this investigation was to explore the clinical relevance of retrograde inferior vena cava or hepatic vein opacification during contrast-enhanced CT. MATERIALS AND METHODS: We retrospectively identified 127 patients who underwent contemporaneous contrast-enhanced CT of the chest or abdomen and echocardiography. On CT, the presence of retrograde inferior vena cava or hepatic vein opacification and the rate of IV contrast injection (> 3 mL/sec, high; < or = 3 mL/sec, low) were recorded. On echocardiography, the presence of tricuspid regurgitation, pulmonary hypertension, or right ventricular systolic dysfunction was recorded. RESULTS: Retrograde inferior vena cava or hepatic vein opacification was more common in studies performed with a high rather than a low contrast injection rate (28/56 vs 6/71 patients, respectively; p < 0.01). This finding was 31% sensitive (5/16) and 98% specific (54/55) for right-sided heart disease at low contrast injection rates, and 81% sensitive (17/21) and 69% specific (24/35) at high injection rates. Multivariate logistic regression models showed that high injection rate, tricuspid regurgitation, pulmonary hypertension, and right ventricular systolic dysfunction were independent predictors of retrograde inferior vena cava or hepatic vein opacification (p < 0.05 for each). CONCLUSION: Retrograde opacification of the inferior vena cava or hepatic veins on CT is a specific but insensitive sign of right-sided heart disease at low contrast injection rates, but the usefulness of this classic sign decreases with high injection rates. This realization is important because many centers increasingly use high-injection-rate CT.     

Comparison of Ultrasound,CT, and MR Imaging in the Evaluation of Candidates for TIPS

To compare ultrasound (US), CT, and MRI in the evaluation of hepatic vascular anatomy, portal and splenic venous flow, and collateral pathways (varices and spontaneous shunts) in candidates for transjugular intrahepatic portosystemic shunting (TIPS), 17 patients with history of refractory variceal bleeding or intractable ascites underwent duplex US, contrast-enhanced CT, and MRI before TIPS. The appearance of portal and hepatic anatomy was graded from 1 (not visible) to 4 (excellent visualization) independently by four radiologists. Presence and direction of portal and splenic venous flow, and presence and location of varices and spontaneous portosystemic shunts were also assessed. Results and effects of interobserver variation were assessed for significance using Friedman's ANOVA and Wilcoxon's signed-rank test. MRI yielded higher scores than CT or US for hepatic veins (P <.0001) and inferior vena cava (P <.0001). MRI and CT scored better than US for portal vein branches (P =.012) and splenic vein (P =.0038). All tests demonstrated the main portal vein well, with no statistically significant difference. US and MRI were more sensitive than CT for detecting portal vein flow and direction (US 76%, CT 0%, MRI 82%). MRI was most sensitive for splenic vein flow and direction (US 41%, CT 0%. MRI 76%). CT and MRI were more sensitive than US in detecting varices (US 5%, CT 50%, MRI 58%) and spontaneous shunts (US 13%, CT 75%, MRI 75%). Interobserver variation did not influence results significantly P =.3691). MRI provides the most useful information and may be the preferred single imaging test prior to TIPS.     

腹内脏器细针穿刺行CO2静脉造影的实验研究

目的探讨细针穿刺腹部脏器组织行CO2静脉造影的可行性和安全性。方法选择健康雌猪2头和雌犬2条，麻醉后，用25G细穿刺针直视下多点穿刺脾、肝、肾、胰腺、小肠和子宫组织。手推法注射CO2行数字减影静脉造影。结果细针穿刺CO2造影可显示脾-门静脉系统、肝静脉、门静脉、肾一下腔静脉、子宫-卵巢静脉，不能显示胰腺和小肠引流静脉。其中，以脾-门静脉系统显示最佳，其影像质量评定结果为A级、B级和C级分别为87．5％(7／8)、12．5％(1／8)和0％；其他依次为肝静脉[A级、B级和C级分别为81．8％(9／11)、18．2％(2／11)和0％]、门静脉[A级、B级和C级分别为77．8％(7／9)、22．2％(2／9)和0％]、肾-下腔静脉[A级、B级和C级分别为38．5％(5／13)、61．5％(8／13)和0％]、子宫．卵巢静脉[A级、B级和C级分别为0％、33．3％(2／6)和66．7％(4／6)]。术中未发现实验动物的重要生命体征发生改变。结论细针直接穿刺部分腹部脏器组织行CO2数字减影静脉造影是安全可行的。     

Membranous obstruction of the inferior vena cava: comparison of findings at sonography, CT, and venography.

OBJECTIVE. Membranous or segmental obstruction of the inferior vena cava is one of the common causes of chronic Budd-Chiari syndrome. In this study, the venographic findings are compared with the results of sonography and CT in order to ascertain their role in the management of these cases. MATERIALS AND METHODS. Fifteen patients with membranous (n = 8) or segmental (n = 7) obstruction of the inferior vena cava who had been examined with sonography and CT were studied retrospectively. Diagnosis was made at surgery (n = 3) or by venacavography (n = 12). Sonographic findings were analyzed on the basis of the initial report, and CT findings were reviewed retrospectively with knowledge of the sonographic findings. RESULTS. Sonography showed membranous obstruction (n = 5), segmental cordlike obstruction (n = 3), and unspecified obstruction (n = 5) of the inferior vena cava, while CT showed a flap of the membrane (n = 1) and segmental narrowing or obstruction of the inferior vena cava (n = 7). In the remaining cases, the inferior vena cava either appeared normal (n = 6) or was not visualized (n = 1) on CT or was not described in the sonographic report (n = 2). In nine cases, CT showed one or several tiny calcific foci in the inferior vena cava. Sonography showed obliteration of at least one hepatic vein (n = 8) and of intrahepatic collateral vessels (n = 12), whereas CT was less sensitive in evaluating obliteration of intrahepatic veins (n = 4) and collateral vessels (n = 7). Sonography and CT both showed hepatic masses (n = 6), evidence of liver cirrhosis and portal hypertension (n = 14), hepatomegaly (n = 14), enlargement of the caudate lobe (n = 9), and intraabdominal (n = 11) and abdominal wall (n = 15) collateral vessels. CONCLUSION. Sonography was superior to CT in delineating pathologic venous anatomy of the inferior vena cava and hepatic veins whereas CT was better in evaluating hepatic cirrhosis and tumor. We believe that these techniques are useful complements to venography in the diagnosis and management of these cases.     

MR angiography of the abdominal veins

On the basis of the time-of-flight effect in 18 normal volunteers and 119 patients with different diseases of the abdominal veins (inferior vena cava, porto-splenic system, renal/hepatic/iliac veins) magnetic resonance (MR) angiograms were compared with the DSA, CT and US results. The MR technique included a series of 2D gradient-echo (Flash) images in which the patients held their breath and projection angiograms (PA) (MIP algorithm). PA of the inferior vena cava and renal veins had a sensitivity of 90% and a specificity of 88.8%. The results demonstrate that in all cases diseases of the large veins could be detected using all the MR information available. It is suggested that this method is so far not satisfactory in the evaluation of small vessels and slow intravascular flow conditions.     

Ultrasonic assessment of abdominal venous return. I. Effect of cardiac action and respiration on mean velocity pattern, cross-sectional area and flow in the inferior vena cava and portal vein

Duplex scanning, i.e. combined real time ultrasonography and pulsed Doppler velocity measurement, of the inferior vena cava and portal vein was performed in 85 patients subjected to routine left and right heart catheterization. Mean blood velocity and volume blood flow in the inferior vena cava were found to be pulsatile, reflecting both cardiac action and respiration. Different flow patterns could be related to various heart conditions. The cross-sectional area of the inferior vena cava was also pulsatile, the normal variation with respiration being partial collapse during inspiration and maximum distension at end expiration. In the majority of patients, portal vein flow showed variation with respiration only, maximum flow occurring during expiration. The flow patterns found in the two veins were well in accordance with previous invasive findings in animals. It is concluded that duplex scanning is a useful tool in the assessment of abdominal venous return.     

CT及MRI对Budd-Chiari综合征中副肝静脉的检测及临床意义

目的 探讨Budd-Chiari综合征中副肝静脉的CT、MRI表现,评价其在Budd-Chiari综合征诊断与治疗中的价值. 资料与方法 有CT、MRI资料的Budd-Chiari综合征病例24例(其中22例行介入诊疗),观察副肝静脉的CT、MRI表现,结合DSA表现和介入治疗方法 讨论副肝静脉的临床意义. 结果 24例Budd-Chiari综合征患者中, 20例检测到副肝静脉, 显示率83.3%.典型的副肝静脉主要分布于肝VI段及临近肝组织内,表现为与下腔静脉相通的管道. 结论 在大多数Budd-Chiari 综合征患者中CT及MRI可以直观地观察副肝静脉的形态、侧支循环情况及其与下腔静脉的交通情况, 对该病的诊断、治疗方案的制定和预后判断都有重要意义.     

三维动态增强磁共振血管成像在肝移植术前的应用

 目的探讨三维动态增强磁共振血管成像(3D DCE MRA)三期扫描技术,评价其在肝移植术前的诊断价值.方法对拟进行肝移植的183例患者进行术前3D DCE MRA成像扫描,采用Siemens Symphony 1.5T超导MRI扫描机,圆形极化相控阵体线圈,3D DCE MRA三期(动脉期、门脉期和静脉期)扫描技术,即对所得图像进行综合评价.结果全部病例均获得了满意的血管成像图像,肝动脉可显示2～3级分支,门静脉可显示2～5级分支,肝静脉可显示1～2级分支.183例肝移植患者,5例显示肝动脉变异,其中2例起自肠系膜上动脉,2例直接起自腹腔干,1例起自胃左动脉.单纯肝硬化门脉高压103例,其中,冠状静脉和食道胃底静脉曲张23例、脐周静脉曲张5例、肠系膜静脉曲张2例、脾门周围静脉曲张30例,门静脉玻璃样变性1例;原发性肝癌79例,5例肝动脉包埋、僵直、推移,2例肝内动-静脉瘘,门静脉右支癌栓23例,门静脉左支癌栓7例,门静脉主干癌栓3例,同时发生门静脉左右支癌栓的2例,MRA表现为门静脉呈半月形或杯口形缺损或不显影.7例肝静脉出现栓塞,5例下腔静脉受压推移,1例下腔静脉瘤栓.结论 3D DCE MRA三期扫描能很好的显示肝动脉、门静脉、肝静脉及下腔静脉系统病变,肝移植术前应用3D DCE MRA,基本达到临床要求,是术前血管评估的有效方法.     

Sudden cardiac arrest during computed tomography examination: clinical findings and "dense abdominal veins" on computed tomography

We report imaging findings in five patients who had sudden cardiac arrest during contrast-enhanced computed tomography (CT). We observed strikingly dense abdominal veins, variable degrees of arterial enhancement, and poor abdominal visceral enhancement. Comparison with a control group of 30 patients revealed a statistically significant increase in mean enhancement of the abdominal veins (including the inferior vena cava, bilateral renal veins, and major tributaries of the hepatic vein) (Kruskal-Wallis test, P< 0.05). These patients lacked any clear cause of cardiac arrest, and the arrest may have been related to an adverse reaction to contrast medium. Despite resuscitation, two patients died and three convalesced. In summary, sudden cardiac arrest is characterized by "dense abdominal veins" on CT in the absence of the cardiac pump function. This effect was presumably the result of forced reflux and stagnation of contrast medium in the abdominal veins without any dilution with the circulating blood, leading to a markedly dense appearance of these venous structures.     

布加综合征合并肝静脉血栓介入治疗的疗效观察

目的 评价布加综合征合并肝静脉血栓介入治疗的临床效果.方法 25例布加综合征合并肝静脉血栓形成的患者,均施行经导管尿激酶溶栓术、球囊扩张术和(或)支架置入术,术后随访采用肝脏超声检查,观察肝静脉、下腔静脉通畅情况及血栓有无复发.介入治疗前后肝静脉-右心房、下腔静脉-右心房压差的比较采用配对t检验.结果 治疗成功23例,其中血栓完全溶解18例,部分溶解5例,肝静脉及下腔静脉血流通畅,肝静脉-右心房压差由术前平均(29±7)cm H2O(1 cm H2O＝0.098 kPa)下降至术后平均(8±3)cm H2O(t=13.7,P＜0.01),下腔静脉-右心房压差由术前平均(19±4)cm H2O下降至术后平均(5±2)cm H2O(t=13.3,P＜0.01);不成功2例.23例患者随访1～42个月,平均(18±10)个月,死亡1例,肝静脉再狭窄2例,经再次球囊扩张治疗成功,其余20例无肝静脉再狭窄及血栓复发.结论 布加综合征合并肝静脉血栓的介入治疗可取得较好临床效果.

Abstract：

Objective To evaluate the effect of interventional therapy for Budd-Chiari syndrome with hepatic vein thrombosis. Methods Twenty-five patients with Budd-Chiari syndrome complicated with hepatic vein thrombosis underwent catheter-directed urokinase thrombolysis, balloon dilation and/or stent placement. During follow-up, re-thrombosis and patency of the recanalized hepatic vein and inferior vena cava were evaluated by liver ultrasound. The pressure gradient of hepatic vein-right atrium or inferior vena cava-right atrium before and after interventional treatment was compared with paired t-test. ResultsTechnical success was obtained in 23 patients. Complete resolution and partial resolution of the thrombi were accomplished in 18 cases and 5 cases, respectively. The recanalized hepatic veins and inferior vena cava were patent. The mean pressure gradient of hepatic vein-right atrium dropped from (29±7) cm H2O to (8±3) cm H2O (1 cm H2O＝0.098 kPa) after the interventional treatment (t=13.7,P<0.01). The mean pressure gradient of inferior vena cava-right atrium dropped from (19±4) cm H2O to (5±2) cm H2O after the interventional treatment (t=13.3, P<0.01). Failures occurred in 2 patients. Over the follow-up period of 1 to 42 months[(18±10) months]after interventional treatment in the 23 patients, one late death occurred. Restenoses of hepatic veins were found in 2 patients, which were all redilated successfully. Neither restenosis of hepatic vein nor recurrence of thrombosis was found in the other 20 patients. Conclusion Interventional therapy could be effectively performed for the treatment of Budd-Chiari syndrome with hepatic vein thrombosis.     

Abdominal thrombotic and ischemic manifestations of the antiphospholipid antibody syndrome: CT findings in 42 patients

PURPOSE: To determine the abdominal computed tomographic (CT) findings in patients with antiphospholipid antibody syndrome (APS). MATERIALS AND METHODS: Retrospective review of medical records from two university medical centers from 1994 through 1997 revealed 215 patients who had a hypercoagulable state attributed to primary or secondary APS. Abdominal CT findings in these patients were reviewed for evidence of large-vessel occlusion or visceral ischemia. RESULTS: In 42 (19.5%) of 215 patients with APS (age range, 32-65 years; mean age, 42 years), abdominal thromboses or ischemic events were detected at CT. Twenty-two (52%) had major vascular thromboses, including those in the inferior vena cava (n = 10), portal and superior mesenteric veins (n = 7), splenic vein (n = 4), and aorta (n = 1). Thirty-six (86%) patients had abdominal visceral ischemia resulting in renal infarction (n = 22), bowel ischemia (n = 13), splenic infarction (n = 6), pancreatitis (n = 3), hepatic infarction (n = 1), and/or hepatic dysfunction with portal hypertension (n = 1). In some patients, more than one abdominal organ and/or vessel was involved. CONCLUSION: Patients who have circulating antiphospholipid antibodies are at risk for major abdominal vascular thromboses and organ infarction. Radiologists must be familiar with this syndrome; they may be the first physicians to suggest the diagnosis on the basis of findings of unusual or recurrent sites of thrombosis, especially in young patients.     

MSCT肝脏血管成像对肝脏移植受体的临床应用价值

目的:探讨64层螺旋CT腹腔干、门静脉及下腔静脉成像技术对肝脏移植受体血管结构评价的临床价值方法:对30例拟行肝脏移植手术的患者行增强后动脉期、门静脉期及下腔静脉期扫描。对每一例病例均行腹腔干、门静脉及下腔静脉三维重建及二维重组并与轴位图像结合分析患者血管情况。根据受体肝脏血管情况筛选出其中24例适宜手术的患者,初步拟定手术方案行肝移植手术,并在手术后与肝移植手术医师的术中探查结果相比较,探讨术前CT血管重建的准确性。结果:腹腔干成像可发现3例腹腔干狭窄,1例腹腔干动脉瘤,2例脾动脉瘤,2例肝脏主要供血动脉直径<3mm,10例肝动脉走行变异。门静脉成像发现2例肝门静脉海绵样变;12例肝门静脉栓塞,其中5例肝内门静脉栓塞,5例肝外门静脉主干栓塞(其中3例合并肠系膜上静脉栓塞);2例肝内门静脉及肝外门静脉主干均有栓塞。2例肝门静脉海绵样变及3例肝外门静脉主干及肠系膜上静脉广泛栓塞的患者因不适宜手术而未能行肝移植手术。下腔静脉成像发现2例下腔静脉癌栓,其中1例栓子接近右心房入口处,不适宜手术未能行肝移植手术;2例下腔静脉肝后段狭窄。30例中24例均成功行肝移植手术,术中所见与CT血管成像所见完全相符合。结论:64层螺旋CT血管成像适合用来全面准确评价拟行肝脏移植的受体的血管状态,对筛选适宜手术的病例并协助手术方案的制定有重要价值。